secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0001493152-24-047606
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Marc Lustig resigns from BriaCell Therapeutics board
-------------------------------------------------------------

- Marc Lustig resigned from the board of directors on November 23, 2024.
- The company thanked Mr. Lustig for his contributions.
- No replacement or further details were provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224047606/0001493152-24-047606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224047606/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer